2019 Global Enteric Diseases Report: VPG Market Research company publishes report on 2019 Enteric Diseases
VPG Market Research is an international market research company which provides global consulting in areas such as healthcare, biotechnology, and food and drink. VPG published a global report on Enteric Diseases this month titled, “Global Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Supplier Shares, Market Segment Forecasts, Competitive Strategies, Technology and Instrumentation Review, Emerging”.
Enteric Diseases are intestinal infections caused by bacteria and are commonly associated with diarrhea. Enteric bacteria typically enters the body through ingestion and is caused by exposure to contaminated food or drink, or infected human and animal feces. According to the Center for Disease Control (CDC), “Every year, millions of cases of foodborne illness and thousands of associated deaths occur in the United States, and the illness burden is even higher in developing countries. Much of this burden could be prevented with better science and prevention tools. We are working to meet national goals to decrease the burden of bacterial diarrheal illness by the year 2020.” The CDC says that many biotechnology companies are working together in order to develop better preventative, diagnostic, and treatment technology to fight against Enteric Disease. The CDC says the major focus right now is “surveillance, investigation, and research” in order to respond promptly to outbreaks, locate their origin, and prevent recurrence in the future.
The report published in October, 2019 by VPG analyzes the current and projected market for Enteric Disease diagnostic technology in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. It provides test volumes and sales projections for each country and market, as well as sales and market share estimates for major enteric diagnostics test suppliers. The report also provides a discussion concerning the most prominent biotechnology on the market such as Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging Technologies. This report is based on interviews with first and secondary sources with leading diagnostic companies, lab-directors, and biotechnology innovation firms.